WM
84
7
OMC
68
2
HSY
66
2
HAL
47
3
IR
80
-5
CB
54
7
ETN
80
-7
AVY
75
-3
PH
67
-4
AMZN
69
4
DRI
61
-2
SPG
64
-2
QRVO
38
-2
KMB
39
2
MSFT
62
-2
INTC
40
5
GE
61
-4
ROK
40
-3
VZ
32
-3
GWW
55
-9
WM
84
7
OMC
68
2
HSY
66
2
HAL
47
3
IR
80
-5
CB
54
7
ETN
80
-7
AVY
75
-3
PH
67
-4
AMZN
69
4
DRI
61
-2
SPG
64
-2
QRVO
38
-2
KMB
39
2
MSFT
62
-2
INTC
40
5
GE
61
-4
ROK
40
-3
VZ
32
-3
GWW
55
-9
Financhill
Back

Jazz Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

Sell
45

JAZZ
Jazz Pharmaceuticals PLC

Last Price:
109.04
Seasonality Move:
51.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Jazz Pharmaceuticals PLC Price Quote

$109.04
-1.45 (-1.31%)
(Updated: May 17, 2024 at 6:55 PM ET)

Jazz Pharmaceuticals PLC Key Stats

Sell
45
Jazz Pharmaceuticals PLC (JAZZ) is a Sell
Day range:
$108.90 - $110.78
52-week range:
$103.01 - $146.70
Dividend yield:
0%
P/E ratio:
18.11
P/S ratio:
1.99
P/B ratio:
1.88%
Volume:
664.7K
Avg. volume:
626.6K
1-year change:
-15.68%
Market cap:
$7B
Revenue:
$3.8B
EPS:
$4.85

How Much Does Jazz Pharmaceuticals PLC Make?

Is Jazz Pharmaceuticals PLC Growing As A Company?

Jazz Pharmaceuticals PLC Stock Price Performance

What Is Jazz Pharmaceuticals PLC 52-Week High & Low?

Jazz Pharmaceuticals PLC Price To Free Cash Flow

Is It Risky To Buy Jazz Pharmaceuticals PLC?

Is Jazz Pharmaceuticals PLC Cash Flow Positive?

  • What Is JAZZ Cash Flow From Operations?
    Cash flow from operations (TTM) is $1B
  • What Is Jazz Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$332M
  • What Is Jazz Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$430.1M

Jazz Pharmaceuticals PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    JAZZ return on invested capital is 3.57%
  • What Is Jazz Pharmaceuticals PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 2.94%
  • What Is JAZZ Return On Equity?
    ROE is a measure of profitability and is 9.3%

Jazz Pharmaceuticals PLC Earnings Date & Stock Price

Jazz Pharmaceuticals PLC Competitors

Jazz Pharmaceuticals PLC Dividend Yield

Data Unavailable

Jazz Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -35.9%
Revenue: 1.03% -5.48%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 182.00
Upside from Last Price: 64.72%

Major Shareholders

  • How many JAZZ shares are owned by institutional investors?
    97.2M JAZZ shares are owned by institutional investors
  • How many JAZZ shares are owned by insiders?
    3.5M JAZZ shares are owned by insiders